Complex TP53 Alterations with del(17p) and del(13q) in Chronic Lymphocytic Leukemia: Clinical Implications from a Case-Based Review
Beata Balla, Andrei Crauciuc, Erzsebet Lazar, Claudia Bănescu · 2026
Read Complex TP53 Alterations with del(17p) and del(13q) in Chronic Lymphocytic Leukemia: Clinical Implications from a Case-Based Review by Beata Balla, Andrei Crauciuc, Erzsebet Lazar, Claudia Bănescu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13361320.txt.
Description
Beata Balla and co-authors present a 2026 case-based review of high-risk gene damage in chronic lymphocytic leukemia. This slow blood cancer varies widely in its genetics, and damage to the TP53 gene is a strong bad sign. The team profiled one patient's cancer with tools that count gene copies and read mutations. The case is rare because several severe faults stacked together.
The patient's cancer had lost parts of two chromosomes and carried two harmful TP53 mutations, wiping out the p53 guard protein. That mix marks a very high-risk profile. Even so, a targeted drug that blocks a B-cell enzyme brought clear improvement in blood measures within six months. The authors stress that TP53 damage outweighs good markers, so full gene checks are a must.
Catalog record
| CREATOR | Beata Balla, Andrei Crauciuc, Erzsebet Lazar, Claudia Bănescu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45518 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |